CCRC - Certified Clinical Research Coordinator Informed Consent Process Questions and Answers

Question 1

A potential participant in a clinical trial is fully fluent in Spanish but has limited English proficiency. The IRB-approved informed consent form (ICF) is only available in English. Which of the following is the most appropriate action for the Clinical Research Coordinator (CRC) to take?

Accepted Answer

Inform the participant they cannot be enrolled until an official, IRB-approved Spanish translation of the ICF is available.

Answer

According to ICH GCP and FDA regulations, the informed consent information must be provided in a language understandable to the subject. Using an unapproved, on-the-spot translation does not meet regulatory standards. The correct and ethical procedure is to use an IRB-approved translated consent form to ensure the participant fully understands the study, its risks, and their rights before providing consent.

Question 2

Which of the following is a primary responsibility of the CRC during the informed consent process?

Accepted Answer

Assessing the potential participant's understanding of the study information provided.

Answer

While the CRC has many roles, a key ethical and regulatory responsibility is to ensure the participant truly understands the study. This involves more than just presenting information; it includes asking open-ended questions, using teach-back methods, and assessing both verbal and non-verbal cues to confirm comprehension before the participant signs the form.

Question 3

A participant has been enrolled in a long-term oncology trial for two years. The sponsor issues a protocol amendment that introduces a new, optional sub-study involving additional blood draws to test for a novel biomarker. What is the CRC's responsibility regarding the informed consent for this change?

Accepted Answer

Ensure the participant is re-consented using a new, IRB-approved consent form that details the optional sub-study.

Answer

Significant new information, such as additional procedures or changes in risk, requires that participants be re-consented. The CRC must use a revised, IRB-approved informed consent form to explain the changes and document the participant's willingness to continue in the trial under the new conditions.

Question 4

According to federal regulations (45 CFR 46 and 21 CFR 50), the informed consent process must minimize the possibility of coercion or undue influence. Which scenario best exemplifies undue influence?

Accepted Answer

An investigator offers an excessively large monetary payment to a financially vulnerable individual to encourage enrollment in a high-risk study.

Answer

Undue influence occurs when an excessive or inappropriate reward is offered to obtain compliance, which can compromise a person's judgment. While compensating participants is acceptable, an amount that is disproportionate to the study's demands, especially when offered to a vulnerable population, is considered undue influence. Telling a patient their care depends on participation is an example of coercion (a threat of harm).

Question 5

During an informed consent discussion for a pediatric study, the CRC must obtain permission from the parents/legal guardian. What additional step is typically required for the pediatric participant?

Accepted Answer

Obtaining the child's assent using an age-appropriate form and discussion.

Answer

For research involving minors who have some capacity to understand, regulations and ethical guidelines require obtaining the child's affirmative agreement, known as assent, in addition to the permission of the parents or legally authorized representative. The assent process and form should be tailored to the child's age and developmental level.

CCRC - Certified Clinical Research Coordinator Practice Test

CCRC - Certified Clinical Research Coordinator Practice Test

CCRC - Certified Clinical Research Coordinator Informed Consent Process Questions and Answers